Company intelligence / Profile preview

Inosep

Ownership: Private
Development stage: Commercial

Overview

INOSEP is a leading company specializing in the development and manufacture of innovative hollow fiber membranes used for blood filtration in medical applications and water purification. The company focuses on sustainable management, aiming to address critical needs in healthcare and environmental sectors through advanced membrane technologies[3].

Therapeutic areas: Infectious DiseasesHematology
Modalities: Device (hollow fiber membrane)Membrane-based filtration technology
Industry: Therapeutic Medical Devices

Partnerships

Partnerships with major universities in Thailand for food science research, new product development, and biotechnology collaborations[2]Collaborations with global membrane manufacturers to develop new applications[2]

Beyond the preview

Go deeper on Inosep.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Inosep.

Explore the full profile